RxDoctor Payments Data

Tony Quinton, DPM

Foot & Ankle Surgery · Anchorage, AKNPI 1639157621

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Integra Lifesciences Corporation at 35.2% of the total. Reporting peaked in 2019 at $254 and has fallen 73.0% since, to $69 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in AK, where the typical reported total is $1,425.

$511in general payments, 2019–2025

Across 17 payments — averaging $30.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Integra Lifesciences Corporation$180
  • Smith+Nephew$129
  • OVIK Health, LLC$56
  • Kerecis Limited$49
  • Stryker$42
  • Averitas Pharma Inc.$24
  • plus $30 from 2 others

What the payments were for

  • Food & beverage$511100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Integra Lifesciences Corporation4$180
Smith+Nephew6$129
OVIK Health, LLC1$56
Kerecis Limited1$49
Stryker2$42
Averitas Pharma Inc.1$24
Merck1$18
KCI USA, Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$511 in reported general payments places this provider in the 25th percentile of 21 foot & ankle surgery providers in Alaska.

See all foot & ankle surgery providers in Alaska

Medicare billing

Part B allowed, 2024
$178,711
Medicare patients
235
Services billed
2,265

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Hyclate41$395
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav29$248

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Anchorage

See the full list for Alaska

Where these figures come from

Is this you, or does something look wrong? →